Buy Zejula (niraparib) Online

0 out of 5

DISEASE INDICATIONS: Gynaecological Cancer MANUFACTURER: Tesaro UK Limited USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Zejula (niraparib) is a drug used for the maintenance treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in adult patients who have responded to platinum-based chemotherapy.

From $5,017.10
Select optionsThis product has multiple variants. The options may be chosen on the product page